NEW YORK, April 27, 2015 /PRNewswire-USNewswire/ — Researchers at NYU Langone Medical Center have discovered that mitochondria, the major energy source for most cells, also play an important role in stem cell development — a purpose notably distinct from the tiny organelle’s traditional job as the cell’s main source of the adenosine triphosphate (ATP) energy […]

(Reuters) – Drug developer Celladon Corp said it expected to announce lay-offs and cost cuts as its stock plunged to an all-time low after the company’s lead experimental gene therapy to treat heart failure failed a key trial. Celladon lost nearly 80 percent of its market value in early trading on Monday, with the stock […]

DALLAS–(BUSINESS WIRE)–Susan G. Komen today hailed the discovery of a breast cancer susceptibility gene known as RECQL which the organization says could one day lead to more options for women to identify and take steps to reduce their breast cancer risk. The discovery project, led by Dr. Mohammad Akbari at the University of Toronto, was […]

VANCOUVER, BC–(Marketwired – April 27, 2015) – Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to announce that its new fusion protein, APC 103, exhibited enhanced activity over the parent protein in retarding tumor growth in animal studies, comparable to APC 101 which has been the Company’s principal […]

STOCKHOLM–(BUSINESS WIRE)–Regulatory News: NeuroVive Pharmaceutical AB (publ)(STO:NVP), the mitochondrial medicine company, announces that the first patient has been enrolled in a clinical phase II study for acute kidney injury using the company’s product CicloMulsion®. The study, known as CiPRICS, is being conducted by Skåne University Hospital and will evaluate the product’s ability to prevent acute […]

STOCKHOLM–(BUSINESS WIRE)–Regulatory News: A Chinese study of infants with colic shows that babies given Lactobacillus reuteri Protectis cry significantly less compared to babies given placebo. The newly published study is the fifth positive colic study with Lactobacillus reuteri Protectis and the results confirm the positive results of earlier studies. 100 per cent treatment successTreatment success […]

More information about the highly anticipated new cholesterol lowering drugs from Amgen and Sanofi/Regeneron emerged today. A new new analysis of available data from early trials with PCSK9 inhibitors adds to the growing evidence showing that the drugs– Amgen’s evolocumab and Sanofi’s alirocumab– dramatically lower LDL cholesterol and offers additional preliminary evidence showing that they are safe and may confer a […]

WICHITA, Kan., April 27, 2015 /PRNewswire-USNewswire/ — For about a century, a known common property of cancer cells is their ability to utilize and catabolize glucose at a high rate. This metabolic alteration of cancer cells is called the ”Warburg phenomenon”, that is an increased flow through glycolysis in spite of high oxygen presence, leading to […]

ATLANTA, April 27, 2015 /PRNewswire-USNewswire/ — A new microneedle patch being developed by the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) could make it easier to vaccinate people against measles and other vaccine-preventable diseases.  The microneedle patch is designed to be administered by minimally trained workers and to simplify […]

(Reuters) – Merck and Co’s diabetes drug Januvia achieved the main goal of a long-awaited heart safety study, according to preliminary results released by the drugmaker on Monday, likely removing a cloud of uncertainty from its biggest product. Merck shares rose nearly 4 percent in after-hours trading following the announcement on Januvia, which had sales […]